To determine which risk factors are associated with serious pancytopenia associated with low dose methotrexate (MTX) therapy.
All Ottawa area rheumatologists, hematologists and dermatologists were surveyed to obtain cases of pancytopenia associated with low dose MTX therapy between 1981 and 1991. Pancytopenia was defined as white blood cells